While Phase 3 trial of RTB101 for respiratory illness did not meet primary endpoint, company presses-on with Parkinson’s trial for TORC1 inhibitor: Results expected...
Age-related macular degeneration can lead to major vision loss. But researchers at Alkahest have announced they are moving forward with trials for a new...
AI start-up NetraMark targets $3 million seed round while identifying that an exciting repurposing candidate has potential for indication expansion into Longevity.
“I won’t tell you...
SENS Foundation business model evolves to focus on spin-outs.
At the recent Longevity Forum in London, one of the keynote sessions was delivered by Dr...
BIOFABICS brings custom design tools to biofabrication.
While still in its infancy, organ-on-chip (OOC) technology is quickly becoming a key growth segment in the Longevity...
Cardiff University is looking to Ervaxx and their Dark Antigens to build on research which could lead to a universal cancer treatment.
Cardiff University’s world...
Exclusive interview: Ambrosia getting back to business after FDA warning.
Research has demonstrated that giving old mice blood transfusions from younger mice shows signs of...
Metallic nanotechnology may turn out to be the most precious way to utilise metals, at least when it comes to increasing healthspan and lifespan.
When...
